- Home
- ZVSA vs ASTI Comparison
ZVSA vs ASTI Comparison
Compare ZVSA & ASTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZVSA
- ASTI
- Stock Information
- Founded
- ZVSA 2014
- ASTI 2005
- Country
- ZVSA United States
- ASTI United States
- Employees
- ZVSA N/A
- ASTI N/A
- Industry
- ZVSA Biotechnology: Pharmaceutical Preparations
- ASTI Semiconductors
- Sector
- ZVSA Health Care
- ASTI Technology
- Exchange
- ZVSA Nasdaq
- ASTI Nasdaq
- Market Cap
- ZVSA 3.5M
- ASTI 3.1M
- IPO Year
- ZVSA N/A
- ASTI N/A
- Fundamental
- Price
- ZVSA $1.22
- ASTI $2.21
- Analyst Decision
- ZVSA Strong Buy
- ASTI
- Analyst Count
- ZVSA 1
- ASTI 0
- Target Price
- ZVSA $240.00
- ASTI N/A
- AVG Volume (30 Days)
- ZVSA 69.7K
- ASTI 29.2K
- Earning Date
- ZVSA 03-24-2025
- ASTI 03-04-2025
- Dividend Yield
- ZVSA N/A
- ASTI N/A
- EPS Growth
- ZVSA N/A
- ASTI N/A
- EPS
- ZVSA N/A
- ASTI N/A
- Revenue
- ZVSA N/A
- ASTI $44,673.00
- Revenue This Year
- ZVSA N/A
- ASTI N/A
- Revenue Next Year
- ZVSA N/A
- ASTI N/A
- P/E Ratio
- ZVSA N/A
- ASTI N/A
- Revenue Growth
- ZVSA N/A
- ASTI N/A
- 52 Week Low
- ZVSA $0.98
- ASTI $1.90
- 52 Week High
- ZVSA $25.00
- ASTI $87.80
- Technical
- Relative Strength Index (RSI)
- ZVSA 44.26
- ASTI 43.64
- Support Level
- ZVSA $1.12
- ASTI $2.14
- Resistance Level
- ZVSA $1.29
- ASTI $2.49
- Average True Range (ATR)
- ZVSA 0.09
- ASTI 0.21
- MACD
- ZVSA -0.01
- ASTI 0.02
- Stochastic Oscillator
- ZVSA 37.04
- ASTI 52.54
About ZVSA ZyVersa Therapeutics Inc.
ZyVersa Therapeutics Inc is a clinical-stage biopharmaceutical company leveraging proprietary technologies to develop drugs for patients with chronic renal or inflammatory diseases with high unmet medical needs. The company has two proprietary globally licensed drug development platforms which are Cholesterol Efflux MediatorTM, VAR 200 (2-hydroxypropyl-beta-cyclodextrin) is an injectable drug in clinical development for the treatment of renal diseases. and IC 100 is a monoclonal antibody inflammasome ASC inhibitor in preclinical development for the treatment of inflammatory conditions.
About ASTI Ascent Solar Technologies Inc.
Ascent Solar Technologies Inc is engaged in the manufacturing and selling of photovoltaic products (PV) solar modules that are flexible, durable, and possess attractive power-to-weight and power-to-area performance. The company is integrating its PV products into scalable and high-value markets such as agrivoltaics, aerospace, satellites, near-earth orbiting vehicles, and fixed-wing unmanned aerial vehicles (UAV). Ascent is also working to expand its portable solar chargers, such as the XD-12. The company markets and sells its products through OEMs, system integrators, distributors, retailers, and e-commerce companies.